UroToday - Overactive Bladder (OAB)

Home

Overactive Bladder (OAB)

Overactive Bladder

Welcome to the UroToday.com Overactive Bladder section! Browse these pages for thousands of resources and information on Overactive Bladder. We update these pages daily so check back regularly for new education and information on diagnosis, treatment and management.

Display

results per page

Results 1 - 15 of 248

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

SUFU 2008 Winter Meeting - POS #BS16 - The Effect of Sacral Nerve Stimulation on Detrusor Function and Structure in the Setting of Bladder Outlet Obstruction - A Rat Model
Friday, 09 May 2008
Introduction and Purpose: Sacral nerve stimulation (SNS) is indicated for the treatment of urinary frequency, urgency, urge incontinence, and non-obstructive urinary retention in patients who have failed conservative management.
Login to read more...

SUFU 2008 Winter Meeting - POS #35 - Urgency Severity and Bother Questionnaire (USBQ) – A New Validated Questionnaire for the Evaluation of Urgency
Friday, 09 May 2008
Introduction and Objectives: Urinary urgency is a key symptom of overactive bladder syndrome (OAB), and may be more bothersome to a patient than the symptom of urinary frequency, but there are few clinically validated tools available for its assessment.
Login to read more...

SUFU 2008 Winter Meeting - POS #38 - Does Treatment of Overactive Bladder (OAB) with Urgency Urinary Incontinence (UUI) with Tolterodine Extended Release (TER) Decrease Rates of Coital Incontinence?
Friday, 09 May 2008
Introduction and Objectives: Coital incontinence is thought be to be related to urethral and/or pelvic floor dysfunction and secondary to stress urinary incontinence.
Login to read more...

SUFU 2008 Winter Meeting - POS #39 - Incomplete Bladder Emptying after Intra-Detrusor Injection of Botulinum Toxin-A
Friday, 09 May 2008
Introduction and Objectives: The intra-detrusor injection of Botulinum toxin-A (BTX-A) is becoming an accepted treatment option for the management detrusor overactivity (DO) refractory to medical management.
Login to read more...

SUFU 2008 Winter Meeting - POS #40 - Botulinum a Toxin for Treatment of Overactive Bladder: What are the Predictors of Elevated PVR Post-Injection?
Friday, 09 May 2008
Introduction and Objectives: Given the paralytic effect of botulinum A toxin, the possibility of urinary retention of this therapy when given for overactive bladder is cautioned in our patients.
Login to read more...

SUFU 2008 Winter Meeting - POS #MP26 - Consider a Diagnosis of Obstructive Sleep Apnea in Patients with Nocturia Even When Daytime Overactive Bladder Syndrome is Present
Wednesday, 07 May 2008
Introduction and Objectives: To corroborate the association between obstructive sleep apnea (OSA) and nocturia among patients with nocturia symptoms, and to explore the association between ultradian sleep cycle and nocturia.
Login to read more...

SUFU 2008 Winter Meeting - POD #16 - Effectiveness and Safety of Transdermal Oxybutynin for Overactive Bladder in Adults Previously Treated with Orally Administrated Oxybutynin
Wednesday, 07 May 2008
Introduction and Objectives: The effectiveness and tolerability of transdermally delivered oxybutynin (OXY-TDS) were studied in adults with overactive bladder (OAB), including those who had been treated previously with orally administered oxybutynin (OXY-oral).
Login to read more...

SUFU 2008 Winter Meeting - POD #17 - Evaluation of the Effect of Injection Volumes of Intravesical Botulinum-A Toxin Injections in Patients with Overactive Bladder Symptoms
Wednesday, 07 May 2008
Introduction and Objectives: Botulinum toxin Type A (BTX) has been shown to be effective in the treatment of patients with detrusor overactivity (DO).
Login to read more...

SUFU 2008 Winter Meeting - POD #18 - Can We Predict Who Will Respond to Botulinum Toxin-A Injections for Idiopathic Overactive Bladder?
Wednesday, 07 May 2008
Introduction: Patients who are refractory to antimuscarinic treatment for idiopathic overactive bladder (I-OAB) are often offered intra-detrusor injection of botulinum toxin-A (BTX-A)for symptom relief.
Login to read more...

SUFU 2008 Winter Meeting - POS #BS19 - Test, Re-Test Reliability, and Development of a Systematic Computer Interface for Assessment of Bladder Autonomic Sensory Function in a Novel Animal Model
Wednesday, 07 May 2008
Introduction and Objectives: We have previously reported on development of a device to measure the bladder sensory perception threshold (BST) in rats using the Neurometer®.
Login to read more...

UroToday Inc. Launches a Unique “No Cost” Online Open Access Journal Focused on Urology and Urologic Oncology
Tuesday, 06 May 2008
BERKELEY, CA, USA (Press Release) - UroToday International Journal® offers authors the ability to submit manuscripts for peer-review free of charge and readers access to full text articles free of charge.
read more

SUFU 2008 Winter Meeting - POD #19 - Urodynamics for Elderly (80 Years Old and More) Females. Who? Why? What?
Monday, 05 May 2008
Introduction and Objectives: Urodynamics is considered as the gold standard for the evaluation of patients with lower urinary tract symptoms (LUTS).
Login to read more...

SUFU 2008 Winter Meeting - POD #20 - The Use of Intra-Detrusor Botulinum Toxin-A in the Elderly
Monday, 05 May 2008
Introduction and Objectives: The intra-detrusor injection of Botulinum toxin-A (BTX-A) is becoming an accepted treatment option for the management of refractory detrusor overactivity (DO).
Login to read more...

SUFU 2008 Winter Meeting - POS #MP24 - Validation of a Real-Time Urodynamic
Monday, 05 May 2008
Introduction and Objectives: To validate a new device, the Urgeometer, for measurement of urinary urgency during urodynamic testing (UDS).
Login to read more...

SUFU 2008 Winter Meeting - POS #BS1 - The Effect of Botulinum Toxin A on Chemical Stimulation of Rat Dorsal Root Ganglion Cells
Friday, 02 May 2008
Introduction and Objectives: Botulinum toxin A (BnTxA) has previously been demonstrated to modulate sensory nerve activity in animal models.
Login to read more...

Focus on Overactive Bladder

New: Poster Presentation
Clinical Proof of Concept Study (BLOSSOM) Shows Novel Beta 3 Adrenoceptor Agonist YM178 is Effective and Well Tolerated in the Treatment of Symptoms of Overactive Bladder

Review
Defining Overactive Bladder as Hypersensitivity

Review
Lower Urinary Tract Symptomatology: Its Definition and Confusion

Review
Overlap of Voiding Symptoms, Storage Symptoms and Pain in Men and Women

Review
Resiniferatoxin and Botulinum Toxin Type A for Treatment of Lower Urinary Tract Symptoms

Abstract
Anticholinergic Drugs Versus Other Medications for Overactive Bladder Syndrome in Adults

Abstract
Long-Term Darifenacin Treatment for Overactive Bladder in Patients Aged 65 Years and Older: Analysis of Results from a 2-Year, Open-Label Extension Study

Overactive Bladder Viewpoints

BJU Int Mini Reviews

- Sacral Neuromodulation for Treating the Symptoms of Overactive Bladder Syndrome and Non-Obstructive Urinary Retention: More Than 10 Years of Clinical Experience

- View

BJU Int Mini Reviews

- Treating Patients with Overactive Bladder Syndrome with Antimuscarinics: Heart Rate Considerations

- View